Meibomian Gland Dysfunction Clinical Trial
Official title:
Effect of Cataract Hyperemulsification Surgery on Meibomian Gland Morphology and Function
Verified date | November 2020 |
Source | Wenzhou Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
50 participants at Eye Hospital of Wenzhou Medical University during August, 2017 to July, 2020 will be enrolled in this study. To study the effect of cataract supermammary surgery on the morphology and function of meibomian glands
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 1, 2020 |
Est. primary completion date | July 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 38 Years to 87 Years |
Eligibility | Inclusion Criteria: - Previously untreated patients with xerophthalmia - Undergoing cataract hyperemulsification surgery Exclusion Criteria: - No history of ocular surgery and trauma - Any eye diseases except xerophthalmia - No treated for xerophthalmia before - Successful completion of follow-ups |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Yune Zhao |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | OSDI scale survey | OSDI scale survey | 08/2017 to 07/2020 | |
Primary | tear meniscus height(mm) | tear meniscus height(mm) | 08/2017 to 07/2020 | |
Primary | first tear film rupture time(s) | first tear film rupture time(s) | 08/2017 to 07/2020 | |
Primary | average tear film rupture time(s) | average tear film rupture time(s) | 08/2017 to 07/2020 | |
Primary | the range of meibomian gland missing(%) | the range of meibomian gland missing(%) | 08/2017 to 07/2020 | |
Primary | meibomian gland average diameter (mm) | meibomian gland average diameter (mm) | 08/2017 to 07/2020 | |
Primary | meibomian gland length (mm) | meibomian gland length (mm) | 08/2017 to 07/2020 | |
Primary | meibomian gland area (mm^2) | meibomian gland area (mm^2) | 08/2017 to 07/2020 | |
Primary | meibomian gland deformation coefficient | meibomian gland deformation coefficient | 08/2017 to 07/2020 | |
Primary | meibomian gland total proportion of glands (%) | meibomian gland total proportion of glands (%) | 08/2017 to 07/2020 | |
Primary | meibomian gland imaging value | meibomian gland imaging value | 08/2017 to 07/2020 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT04884243 -
Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
|
Phase 2 | |
Active, not recruiting |
NCT04425551 -
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction
|
N/A | |
Terminated |
NCT02596919 -
Fast Infrared Meibography (Photography)
|
N/A | |
Completed |
NCT01207752 -
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
|
N/A | |
Completed |
NCT05162261 -
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
Recruiting |
NCT06064071 -
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
|
N/A | |
Completed |
NCT03652051 -
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
|
Phase 2 | |
Recruiting |
NCT03767530 -
Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
Active, not recruiting |
NCT05577910 -
Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD
|
N/A | |
Completed |
NCT04889950 -
Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction
|
N/A | |
Recruiting |
NCT06004895 -
Mechanisms of Light-based Therapies for Dry Eye Disease
|
N/A | |
Completed |
NCT04147962 -
Intense Pulsed Light in Meibomian Gland Dysfunctions
|
||
Completed |
NCT02256969 -
Intraductal Meibomian Gland Probing Trial
|
Phase 4 | |
Recruiting |
NCT05089591 -
Intense Pulsed Light in Meibomian Gland Dysfunction
|
N/A | |
Completed |
NCT04500821 -
Evaluation of the LipiFlow System With a New Activator
|
N/A | |
Completed |
NCT03318874 -
Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
|
Phase 4 | |
Completed |
NCT06278584 -
iLux Treatment for Meibomian Gland Dysfunction
|
N/A | |
Recruiting |
NCT04052841 -
Morphological Analysis of Meibomian Glands
|
N/A | |
Completed |
NCT05028491 -
The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients
|